National Centre for
Pharmacoeconomics
NCPE Ireland
About Us
Current Staff
News
Glossary
Contact Us
Home
Submission Process
HTA Guidelines
Process Flowchart
Submission Templates
Pharmacoeconomic Evaluations
Drugs
Vaccines
Diagnostics and Other Technologies
Publications
Peer Reviewed Papers
Abstracts
Reports
Research
Pharmacoeconomic Research
Education
COVID-19
For Patients
Drugs
:
P
A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
R
S
T
U
V
Z
Pertuzumab (Perjeta®) in neoadjuvant HER2 positive breast cancer
Pertuzumab and trastuzumab (Phesgo®). HTA ID: 20053
Phenylephrine Hydrochloride, Tropicamide & Lidocaine Hydrochloride (Fydrane®)
Piperaquine tetraphosphate/dihidroartemisinin (Eurartesim®)
Pirfenidone (Esbriet®)
Pitavastatin (Livazo®)
Pitolisant hydrochloride (Wakix®)
Pixantrone (Pixuvri®)
Polatuzumab vedotin (Polivy®) HTA ID: 19052
Polatuzumab vedotin (Polivy®). HTA ID: 22043
Previous Page
1
2
3
4
5
6
Next Page
health check